FDA Investigator Amatul H Marium
Amatul H Marium has inspections in 1 countries as of 19 Sep 2023. Amatul H Marium has collaborated with a combined 1240 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
10
Last Inspection Date:
19 Sep 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alberto A Viciedo,
Alice S Tsao,
Althea A Williams,
Anthony J Donato,
Barbara J Maulfair,
Bijoy Panicker,
Christopher S Fields,
David R Delucia,
Deborah B Nixon,
Demitria J Xiradakis,
Dongping Dai, PhD,
Douglas C Kovacs,
Douglas G Ng,
Dr. Robert C Horan, MD,
Emmanuel J Ramos,
Felix Maldonado,
Gam S Zamil,
Gary J Lehr,
Guerlain Ulysse,
Iram R Hassan, PhD,
James A Liubicich,
Jay T Wong,
Jonee J Mearns,
Jose O Hernandez,
Josh Renzon Ramilo,
Karen E D'orazio,
Karen L Kosar,
Karishma G Gopaul,
Keith M Reilly,
Kenneth H Williams,
Kim Lthomas Cruse,
Kim Thomasc Rice,
Lata C Mathew, PhD,
Lawrence W Farina,
Liatte Kreuger, PharmD,
Marisa R Eschmann,
Melba Trivera Clavell,
Meredith P Soehl, Investigator,
Michael Serrano,
Mindy M Chou,
Miral B Patel,
Neil J Bonzagni, PhD MPH,
Niketa Patel,
Parul M Patel,
Patrick C Klotzbuecher,
Paul L Bellamy,
Paul Mouris,
Peter Abel,
Peter Caparelli,
Peter R Caparelli,
Peter R Lenahan,
Peter S Diak,
Rachael A Moliver,
Robert C Steyert,
Rochelle K Kimmel,
Rose Xu,
Samina S Khan,
Sony Mathews,
Syeda N Mahazabin,
Tanya R Syffrard,
Tara G Bizjak,
Tara K Carmody,
Tara K Normandin,
Tara R Gooen,
Thomas J Mooney,
Uduak M Inokon,
Valerie C Reed,
Valerie Reed,
Victoria Spivak,
Vivin George,
Yvesna C Blaise
Amatul H Marium's Documents
Publish Date | Document Type | Title |
---|---|---|
November, 2022 | FDA 483 | Pharbest Pharmaceuticals, Inc. - Form 483, 2022-11-10 |
July, 2022 | FDA 483 | Brittonfield Laboratories - Form 483, 2022-07-08 |
September, 2023 | FDA 483 | InvaGen Pharmaceuticals, Inc - Form 483, 2023-09-19 |
June, 2023 | FDA 483 | Amneal Pharmaceuticals of New York, LLC - Form 483, 2023-06-07 |
March, 2023 | FDA 483 | Saptalis Pharmaceuticals LLC - Form 483, 2023-03-17 |
August, 2023 | FDA 483 | SGS North America Inc. - Form 483, 2023-08-01 |
August, 2022 | FDA 483 | Fougera Pharmaceuticals Inc. - Form 483, 2022-08-10 |
November, 2023 | FDA 483 | Fougera Pharmaceuticals Inc. - Form 483, 2023-11-17 |
December, 2023 | FDA 483 | Madcar A Division of Century Direct Solutions - Form 483, 2023-12-20 |
March, 2024 | FDA 483 | Island Testing and Tech Services LLC - Form 483, 2024-03-28 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more